Study on Amentotaxus Bilfavone Distribution in Rats'Tissues
10.11842/wst.2015.03.020
- VernacularTitle:穗花杉双黄酮在大鼠体内的组织分布研究
- Author:
Yanzhi WANG
;
Meng ZHANG
;
Yang LIU
;
Huili ZHAO
;
Xiaoke ZHENG
- Publication Type:Journal Article
- Keywords:
Amentotaxus biflavone;
rat;
tissue distribution;
HPLC
- From:
World Science and Technology-Modernization of Traditional Chinese Medicine
2015;17(3):536-543
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to establish an analysis method of amentotaxus biflavone distribution in rats' tissues, including the heart, liver, spleen, lungs, kidney, brain, stomach, large intestine and small intestine, in order to investigate its distribution characteristics in tissues after rats gavaged with amentotaxus biflavone. HPLC-UV was employed to determine contents of amentotaxus biflavone in rats' tissues. The intragastric administration dose of amentotaxus biflavone was 500 mg·kg-1. Rats were sacrificed by cervical dislocation 10 min, 0.5, 1, 2, 4, 8, 12 h after intragastric administration. Tissues of the heart, liver, spleen, lungs, kidney, stomach, large intestine, small intestine and brain were removed and dissected immediately. Distribution of amentotaxus biflavone in each tissue was determined after processing. The results showed that tissue in different range had a good linear range. The lowest detection limit was 0.125 ng. The RSD of intra and inter-day was less than 10%. The absolute recovery rate of amentotaxus biflavone in each tissue was between 75.07% and 89.80%. The relative recovery rate was between 92.00% and 107.00%. Amentotaxus biflavone in each tissue was stable in different tissues in refrigerator of -20° C for 15 days. It was concluded that there were relatively large concentration differences of amentotaxus biflavone in different tissues. After intragastric administration, amentotaxus biflavone was mainly distributed in the stomach, large intestine, small intestine, liver and kidney, and then the heart, lungs and spleen. It also distributed in brain tissues through the blood-brain barrier.
